---

$5.87

-0.6850 ( -10.50% ) 182.9K

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-01-04	Sale	-178000.00	COX CARRIE SMITH
2024-01-04	Sale	-178000.00	Singer Michael
2024-01-04	Sale	-2424000.00	Davis Blaine
2024-01-04	Sale	-778200.00	Jewell Christopher M
2024-01-04	Sale	-4654100.00	Brunn Carsten
2024-01-04	Sale	-178000.00	Sallin Aymeric
2024-01-04	Sale	-178000.00	BARABE TIMOTHY C
2024-01-04	Sale	-178000.00	SPRINGER TIMOTHY A
2024-01-04	Sale	-548200.00	Miljkovic Milos
2024-01-04	Sale	-178000.00	ZENNER PATRICK J